Outcome achieved.
The market might want to see a first quarter of Adheris revenue under MDR before the share price lifts.
- Raising approximately AUD $35 million, exceeding the minimum required to complete the acquisition of Adheris Health.
- Adheris’ strong sales pipeline of health programs relating to pharmaceuticals and vaccines built this quarter provides confidence for FY21 sales growth.
- Major shareholder HMS and a number MedAdvisor directors have participated in the round.
Outcome achieved. Raising approximately AUD $35 million,...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MDR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
50.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $278.4M | |||
| Open | High | Low | Value | Volume |
| 51.0¢ | 52.0¢ | 50.5¢ | $88.33K | 172.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 23690 | 50.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 51.0¢ | 14081 | 1 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| MDR (ASX) Chart |